Spreadability measurements to assess structural equivalence (Q3) of topical formulations--a technical note.
作者信息
Kryscio David R, Sathe Pradeep M, Lionberger Robert, Yu Lawrence, Bell Michael A, Jay Michael, Hilt J Zach
机构信息
Department of Chemical and Materials Engineering, University of Kentucky, 177 F. Paul Anderson Tower, Lexington, Kentucky 40506, USA.
出版信息
AAPS PharmSciTech. 2008;9(1):84-6. doi: 10.1208/s12249-007-9009-5. Epub 2008 Jan 12.
Abstract
摘要
相似文献
1
Spreadability measurements to assess structural equivalence (Q3) of topical formulations--a technical note.
AAPS PharmSciTech. 2008;9(1):84-6. doi: 10.1208/s12249-007-9009-5. Epub 2008 Jan 12.
2
The case for standardizing the appearance of bioequivalent medications.
J Manag Care Pharm. 2011 May;17(4):321-3. doi: 10.18553/jmcp.2011.17.4.321.
3
Development of performance matrix for generic product equivalence of acyclovir topical creams.
Int J Pharm. 2014 Nov 20;475(1-2):110-22. doi: 10.1016/j.ijpharm.2014.07.034. Epub 2014 Jul 30.
4
Establishing "abuse-deterrence equivalence" for generic abuse-deterrent opioid formulations: A proposed development framework.
J Opioid Manag. 2016 May-Jun;12(2):96-100. doi: 10.5055/jom.2016.0320.
5
Bioequivalence of topical generic products. Part 1: Where are we now?
Eur J Pharm Sci. 2018 Oct 15;123:260-267. doi: 10.1016/j.ejps.2018.07.050. Epub 2018 Jul 24.
6
The protein science of biosimilars.
Nephrol Dial Transplant. 2006 Oct;21 Suppl 5:v4-8. doi: 10.1093/ndt/gfl474.
7
Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment.
Clin Ther. 1991 Nov-Dec;13(6):687-94.
8
[Bioequivalence of dermatological topical medicines:the Brazilian scenario and the challenges for health surveillance].
Cien Saude Colet. 2015 Nov;20(11):3599-608. doi: 10.1590/1413-812320152011.01082015.
9
Light-sensitive drugs in topical formulations: stability indicating methods and photostabilization strategies.
Future Med Chem. 2017 Oct;9(15):1795-1808. doi: 10.4155/fmc-2017-0105. Epub 2017 Sep 19.
10
Generic versus brand-name North American topical glaucoma drops.
Can J Ophthalmol. 2012 Feb;47(1):55-61. doi: 10.1016/j.jcjo.2011.12.004.
引用本文的文献
1
Intact NMR Approach Quickly Reveals Synchronized Microstructural Changes in Oil-in-Water Nanoemulsion Formulations.
AAPS J. 2024 Jul 9;26(4):78. doi: 10.1208/s12248-024-00945-3.
2
Formulation of Topical Flurbiprofen Solid Lipid Nanoparticle Gel Formulation Using Hot Melt Extrusion Technique.
AAPS PharmSciTech. 2022 Sep 16;23(7):257. doi: 10.1208/s12249-022-02410-w.
3
Application of Confocal Raman Microscopy for the Characterization of Topical Semisolid Formulations and their Penetration into Human Skin Ex Vivo.
Pharm Res. 2022 May;39(5):935-948. doi: 10.1007/s11095-022-03245-7. Epub 2022 Apr 11.
4
The Implications of Regulatory Framework for Topical Semisolid Drug Products: From Critical Quality and Performance Attributes towards Establishing Bioequivalence.
Pharmaceutics. 2021 May 13;13(5):710. doi: 10.3390/pharmaceutics13050710.
5
Influence of Inter- and Intra-Batch Variability on the Sample Size Required for Demonstration of Equivalent Microstructure of Semisolid Dosage Forms.
Pharmaceutics. 2020 Nov 28;12(12):1159. doi: 10.3390/pharmaceutics12121159.
6
Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence.
Pharmaceutics. 2019 Oct 1;11(10):503. doi: 10.3390/pharmaceutics11100503.
7
Topical Formulation Comprising Fatty Acid Extract from Cod Liver Oil: Development, Evaluation and Stability Studies.
Mar Drugs. 2016 Jun 1;14(6):105. doi: 10.3390/md14060105.
本文引用的文献
1
Progress in methodologies for evaluating bioequivalence of topical formulations.
Am J Clin Dermatol. 2001;2(5):275-80. doi: 10.2165/00128071-200102050-00001.
2
Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence.
Pharm Res. 1998 Feb;15(2):167-71. doi: 10.1023/a:1011941929495.
Zotero 插件